Cárdenas M

Language: Spanish
References: 10
Page: 9-13
PDF size: 140.35 Kb.

ABSTRACT

Atrial fibrillation is an arrhythmia characterized by no-coordinated atrial contraction that results in an inefficient atrial systole. The clinical classification of atrial fibrillation includes: ocassional, paroxysmal, persistent, and permanent. Multiple mechanisms have been described and accounts for a single ECG manifestation. Treatment should be individualized and has to considered several aspects including age, associated heart disease, and symptoms. Treatment strategies are: rhythm control, rate control, and thromboprophylaxis.

REFERENCES

1. Lewis T: Auricular fibrillation a common clinical condition. Brit Med J 1909; (II):1528.

2. Cárdenas M: La clínica de las arritmias. Prensa Med Méx. México 1987.

3. Allesie M, Janse MJ: Mechanisms of atrial arrhythmias. En: Single BN, Wellens HJ, Hiroaka M. Electropharmacological control of cardiac arrhythmias. New York Futura Publishing Co 1994.

4. Haissaguerre M, Marcus FI, Fischer B, Clementy J: Radiofrequency ablation in inusual mechanisms of atrial fibrillation. J Card Electrophysiology 1994; 5: 1973.

5. Márquez MF, Iturralde-Torres P, Colín Lizalde L, Nava Townsed S, González Aceves EN, Hermosillo JA Martínez Ríos MA, Victoria Romero DR, Cárdenas M: Estudio electrofisiológico y ablación de actividad eléctrica anormal en venas pulmonares de pacientes con fibrilación auricular paroxística idiopática. Gac Med Mex 2006; 142: 43-47.

6. Pappone C, Rosario S, Oreto G, Tocehi M, Gugliotta V, Vicedomine G: Circumferential radio ablation of pulmonary veins ostia: a new anatomic approach for curing atrial fibrillation. Circulation 2000; 102: 2619-e28.

7. De Demus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA: Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Int Med 2005; 165: 258-262.

8. Singer DE, Albers GW, Dalin JE, Go AS, Halperin JL, Manning WJ: Antithrombotic therapy in atrial fibrillation: The seventh ACCP Conference on Antithrombotic and Thrombolitic therapy. Chest 2004; 126: 4295-4565.

9. ISNH AF World-Wide Internet Symposium: Papel de las drogas antiarrítmicas en la FA. 2006; 14: 1-14.

10. Fuster J, Ryden LE, Asinger RW, ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the ACC/AHA task force on practice guidelines and The European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines) for the Management of Atrial Fibrillation developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 2001; 22: 1852-1923.